Becker's Healthcare January 9, 2025
Jakob Emerson

Personalized health navigation company Transcarent is planning to purchase health benefits navigator Accolade for $621 million.

Transcarent plans to acquire Accolade for $7.03 per share in cash in the second quarter of 2025, according to a Jan. 8 news release.

The deal is being financed by General Catalyst and Glen Tullman’s 62 Ventures....

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Insurance, Mergers & Acquisitions / JV, Provider, Self-insured, Technology, Trends
Accolade Gets a Do-Over With Transcarent’s $621M Acquisition
Transcarent to acquire fellow health benefits navigator Accolade for $621M
Transcarent To Acquire Accolade
Transcarent to acquire Accolade for $621 million
How Can Self-Insured Employers Identify Ways to Rein in Healthcare Costs?

Share This Article